| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 01/20/2005 | CA2530450A1 5-substituted quinazolinone derivatives |
| 01/19/2005 | EP1497296A1 1,4 DIAZOCINO 7,8,1-hi INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | EP0777492B1 Combinatorial libraries of substrate-bound cyclic organic compounds |
| 01/19/2005 | CN1566116A Process for preparing wedelia lactone and application thereof |
| 01/19/2005 | CN1566100A Aporphine and ketone group aporphine compound and medicinal use thereof |
| 01/19/2005 | CN1185214C Novel indeno indolone compound, its preparation method and drug composition comprising the same |
| 01/18/2005 | US6844445 Central nervous system disorders; psychological disorders |
| 01/18/2005 | US6844352 1′-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4′-piperidine] hydrohalogenides |
| 01/18/2005 | US6844350 Febrifugine, isofebrifugine and method for producing the same |
| 01/13/2005 | WO2005003137A1 Salinosporamides and methods for use thereof |
| 01/13/2005 | WO2005003132A1 Perylenetetracarboxylic acid dibenzimidazole sulfoderivatives containing oxo-groups in the perylene core which form part of a para-quinoid system of bonds, lyotropic liquid crystal systems and anisotropic films containing the same, and methods for making the same |
| 01/13/2005 | WO2005003128A1 Thiazolylpiperidine derivatives as mtp inhibitors |
| 01/13/2005 | WO2005003097A1 Cis-2,4,5-triaryl-imidazolines |
| 01/13/2005 | WO2005003086A2 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 01/13/2005 | WO2005002577A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 01/13/2005 | WO2005002503A2 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 01/13/2005 | WO2004096805A3 Lyotropic liquid crystal systems based on sulfonated perylenetetracarboxylic acid dibenzimidazoles |
| 01/13/2005 | WO2004050035A3 Benzimidazoles and analogs thereof as antivirals |
| 01/13/2005 | US20050010046 Topoisomerase poison agents |
| 01/13/2005 | US20050009898 New substituted indolinones, their manufacture and their use as medicaments |
| 01/13/2005 | US20050009894 Benzimidazole derivatives and their use as KDR kinase protein inhibitors |
| 01/13/2005 | US20050009855 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives; these compounds interfere with the E1-E2-DNA complex during initiation of DNA replication |
| 01/13/2005 | US20050009830 Fused ring cinnoline derivatives including naphthocinnolines, quinollinocinnolines and naphthopyridinopyridines, e.g., 2,3-Dimethoxydibenzo[ch]cinnoline and 2,3-Dimethoxy-8,9-methylenedioxy-dibenzo[c,h]cinnoline; treatment of anticancer agnets, fungicides and bactericides |
| 01/13/2005 | US20050009826 5,6,13-trizaza- or 6,13-diazachryseno[2,3-d]-[1,3]dioxole derivatives; enzyme inhibitors; anticarcinogenic, antiproliferative agents; bactericides, fungicides |
| 01/13/2005 | US20050009825 Cytotoxic agents |
| 01/13/2005 | US20050009824 Solubilized topoisomerase poisons |
| 01/13/2005 | US20050009823 E.g., derivatives of pyrazolo[1,5-a]pyrimidines; [1,2,3]triazolo[4,5-b]pyridines; and pyrrolo[3,2-d]pyrimidines and their use as corticotropin releasing factor antagonists |
| 01/13/2005 | US20050009820 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 01/13/2005 | US20050009755 (74)(3S)-3-amino-1-(1-benzyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl)-5-methyl-2-heptanone for example; cysteine protease inhibitors; treating bone resorption diseases such as osteoporosis |
| 01/13/2005 | CA2530886A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 01/13/2005 | CA2530215A1 Salinosporamides and methods for use thereof |
| 01/13/2005 | CA2528119A1 Cis-2,4,5-triaryl-imidazolines |
| 01/13/2005 | CA2525580A1 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 01/12/2005 | EP1496060A1 Antitumoral analogs of ET-743 |
| 01/12/2005 | EP1495022A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 01/12/2005 | EP1495014A2 Novel flavanoids and chalcones as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 01/12/2005 | EP1495000A1 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers |
| 01/12/2005 | EP1494672A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity |
| 01/12/2005 | EP1494670A1 Medicine for treating cancer |
| 01/12/2005 | CN1564818A Process for stereoselective synthesis of 2-hydroxymethyl chromans |
| 01/11/2005 | US6841304 Dissolves other salts, in particular metallic salts, such as lithium salts, to give highly conductive solutions |
| 01/11/2005 | CA2215351C Process for isolating galanthamine |
| 01/06/2005 | WO2005000842A1 Benzothiazole derivatives as adenosine receptor ligands |
| 01/06/2005 | WO2005000250A2 Imaging agents and methods of imaging alpha 7-nicotinic cholinergic receptor |
| 01/06/2005 | WO2004103967A3 Thiocarbamate inhibitors of alpha-4 integrins |
| 01/06/2005 | WO2004071382A3 Substituted heterocycles |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004159 for example, 8-(1-ethylpropyl)-3-mesityl-2,5-dimethyl-8H-pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine; having an excellent corticotrophin-releasing-factor receptor antagonistic activity |
| 01/06/2005 | US20050004157 Serotonin uptake inhibitors and 5-HT1A receptor antagonists; antidepressants; psychological disorders |
| 01/06/2005 | US20050004147 Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it |
| 01/06/2005 | US20050004143 Bi-cyclic pyrimidine inhibitors of TGFbeta |
| 01/06/2005 | US20050004142 furo(2,3-d)pyrimidine and thieno(2,3-d)pyrimidine compounds for treating cancer and hyperproliferative diseases; receptor tyrosine kinase inhibitors |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
| 01/06/2005 | US20050004130 New metabotropic glutamate receptor compounds |
| 01/06/2005 | US20050004124 Synergistic mixture; antidiabetic agents; antiischemic agents |
| 01/06/2005 | US20050004112 C-fms kinase inhibitors |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004099 Spiroazabicyclic heterocyclic compounds |
| 01/06/2005 | US20050004039 Selective analgesic agents |
| 01/06/2005 | US20050001202 Perylenetetracarboxylic acid dibenzimidazole sulfoderivatives containing oxo-groups in the perylene core which form part of a para-quinoid system of bonds, lyotropic liquid crystal systems and anisotropic films containing the same, and methods for making the same |
| 01/06/2005 | CA2672071A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/05/2005 | EP1493738A1 Epothilone derivatives |
| 01/05/2005 | EP1493057A1 Colour photographic recording material |
| 01/05/2005 | EP1492571A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 01/05/2005 | EP1492539A1 Statin therapy for enhancing cognitive maintenance |
| 01/05/2005 | EP1492536A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 01/05/2005 | CN1561215A Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid compounds used as nmda antagonist |
| 01/05/2005 | CN1183138C Process for promoting generation of 10-hydroxycamptothecin in the bud of camptotheca seed |
| 01/05/2005 | CN1183137C Synthesis method of [3aS, 6aR]-1,3-dibenzyl-tetrahydro-4H-fruo [3,4-d]-imidazolyl-2,4[1H}-diketone [I] |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | US6838527 Polymer-immobilized α-iminoester |
| 01/04/2005 | US6838477 Lactacystin analogs |
| 01/04/2005 | US6838471 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| 01/04/2005 | US6838457 Fused heteroaryl derivatives |
| 01/04/2005 | US6838291 For identifying compounds that bind to ion channel and may have antiarrhythmic activity |
| 01/04/2005 | CA2242015C New chromene derivatives, the procedure for preparing them and the pharmaceutical compounds that contain them |
| 01/04/2005 | CA2186015C Nicotinic acid derivatives and herbicides |
| 01/04/2005 | CA2093076C 2- and 3-amino and azido derivatives of 1,5-iminosugars |
| 12/30/2004 | US20040266840 Inhibits replication and/or proliferation of Hepatitis C virus (HCV) |
| 12/30/2004 | US20040266821 Obesity, diabetes, sexual dysfunction |
| 12/30/2004 | US20040266804 Camptothecin analogs having an E-ring ketone |
| 12/30/2004 | US20040266803 7-Substituted camptothecin and camptothecin analogs and methods for producing the same |
| 12/30/2004 | US20040266759 Possess antithrombotic and anticoagulant properties; example compound: 1-(5-Chlorobenzo[b]furan-2-ylsulphonyl)-4-[4-(4-pyridyl)benzoyl]piperazine |
| 12/30/2004 | US20040266758 Modulators of the glucocorticoid receptor and method |
| 12/30/2004 | US20040266753 Benzo[a]pyrano[3,2-h]acridin-7-one compounds |
| 12/30/2004 | DE10326386A1 N-Heterocyclyl-phenylsubstituierte cyclische Ketoenole N-heterocyclyl-substituted cyclic ketoenols |
| 12/29/2004 | WO2004113394A2 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom |
| 12/29/2004 | WO2004113345A1 Fused pyrrole compound and medicinal use thereof |
| 12/29/2004 | WO2004075853A3 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 12/29/2004 | EP1491544A1 Benzo[a]pyrano[3,2-h]acridin-7-one derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 12/29/2004 | EP1491541A1 Pyridazinone aldose reductase inhibitors |
| 12/29/2004 | EP1491540A1 Pyridazinone aldose reductase inhibitors |
| 12/29/2004 | EP1491353A1 Optical recording media and dipyrromethene-metal chelate compounds |
| 12/29/2004 | EP1490361A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 12/29/2004 | EP1490356A1 (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 12/29/2004 | EP1490058A1 Peroxisome proliferator activated receptor modulators |
| 12/29/2004 | EP1490047A2 Certain pharmaceutically useful substituted aminoalkyl heterocycles |
| 12/29/2004 | EP1373259B1 Pyridazinone aldose reductase inhibitors |